REFERENCES
- Mendes D, Correia M, Barbedo M, . Behçet’s disease—a contemporary review. J Autoimmun. 2009;32:178–188.
- Belmouaz S, Sechet A, Fernandez B, . Tubulo-interstitial nephritis with Fanconi syndrome in Behçet disease. Nephrol Dial Transplant. 2007;22:2079–2083.
- Magro-Checa C, Navas-Parejo Casado A, Borrego-García E, . Successful use of tocilizumab in a patient with nephrotic syndrome due to a rapidly progressing AA amyloidosis secondary to latent tuberculosis. Amyloid. 2011;18:235–239.
- Sahin I, Noyan T, Karaman E, Yalçmkaya AS, Metin A, Akpolat T. Mild renal injury in Behçet´s Disease. Ren Fail. 2004;26:55–57.
- Nadir I, Gültekin F, Yönem O, Yildiz EA. Behçet case with renal amyloidosis. Ren Fail. 2003;25:323–326.
- Kutlay S, Civriz S, Ensari A, Nergizoglu G, Ates K, Karatan O. Development of amyloidosis in Behçet’s syndrome with isolated mucocutaneous involvement. Rheumatol Int. 2004;24:37–39.
- Kosemehmetoglu K, Baydar DE. Renal amyloidosis in Behçet´s disease: clinicopathologic features of 8 cases. Int Urol Nephrol. 2012; Sep 9. [Epub ahead of print].
- Akpolat T, Dilek M, Aksu K, . Renal Behçet’s disease: an update. Semin Arthritis Rheum. 2008;38:241–248.
- Skhiri H, Mahjoub S, Harzallah O, . Secondary amyloidosis, a fatal complication of Behçet´disease: three case reports. Saudi J Kidney Dis Transpl. 2004;15:57–60.
- Melikoglu M, Altiparmak MR, Fresko I, . A reappraisal of amyloidosis in Behçet´syndrome. Rheumatology. 2001;40:212–215.
- Pay S, Simşek I, Erdem H, Dinç A. Immunopathogenesis of Behçet’s disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int. 2007;27:417–424.
- Hamzaoui K, Hamzaoui A, Guemira F, Bessioud M, Hamza M, Ayed K. Cytokine profile in Behçet’s disease patients. Relationship with disease activity. Scand J Rheumatol. 2002;31:205–210.
- Evereklioglu C, Er H, Türköz Y, Cekmen M. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet’s disease. Mediators Inflamm. 2002;11:87–93.
- Hirano T, Ohguro N, Hohki S, . A case of Behçet’s disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab. Mod Rheumatol. 2012;22:298–302.